loadpatents
Patent applications and USPTO patent grants for MEDICAL RESEARCH COUNCIL TECHNOLOGY.The latest application filed is for "compounds".
Patent | Date |
---|---|
Anti-transglutaminase 2 antibodies Grant 10,005,846 - Johnson , et al. June 26, 2 | 2018-06-26 |
Compounds App 20170320870 - MCIVER; Edward Giles ;   et al. | 2017-11-09 |
Hepatitis C virus antibodies Grant 9,193,781 - Matthews , et al. November 24, 2 | 2015-11-24 |
Anti-transglutaminase 2 Antibodies App 20150218289 - Johnson; Tim ;   et al. | 2015-08-06 |
Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK Grant 8,569,281 - Chan , et al. October 29, 2 | 2013-10-29 |
Pyrazolopyridines As Inhibitors Of The Kinase Lrrk2 App 20130267513 - Chan; Brayn ;   et al. | 2013-10-10 |
Sustained release of microcrystalline peptide suspensions Grant 8,415,300 - Deghenghi , et al. April 9, 2 | 2013-04-09 |
Pyrrolopyrimidines And Used As Kinase Inhibitors App 20120088753 - Mciver; Edward Giles ;   et al. | 2012-04-12 |
Compounds App 20100317646 - Mciver; Edward Giles ;   et al. | 2010-12-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.